ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,719.60
0.21%
다우존스 지수
39,512.84
0.32%
Bitcoin
63,085.42
2.66%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Daxor Corporation (DXR)

  7. Daxor Corporation (DXR) 뉴스

DXR Daxor Corporation

9.5527
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:16:16
15분 지연
기업명 주식 심볼 시장 주식 타입
Daxor Corporation DXR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 9.5527 17:16:16
개장가 저가 고가 종가 전일 종가
9.5527
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202421:00GLOBENew Studies Prove the Clinical Benefits of Daxor’s Blood..
15/04/202421:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
10/04/202421:00GLOBEDaxor Corporation Announces New Hospital Account at Leading..
01/04/202421:00GLOBEDaxor Corporation to Exhibit at the American College of..
25/03/202421:00GLOBEDaxor Corporation Acquires Volumex® and Megatope® From Its..
22/03/202421:00GLOBEDaxor Corporation to Hold Investor Call Discussing Fiscal..
19/03/202403:18GLOBEDaxor Corporation CEO and President Michael Feldschuh..
11/03/202421:00GLOBEDaxor Announces Sales to Three New Hospitals Furthering..
09/03/202403:49EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
08/03/202422:00GLOBEMulti-Center Study Presented by Duke at Heart Failure..
07/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:28EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
01/03/202406:15EDGAR2Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of..
26/02/202422:00GLOBEDaxor Corporation to Exhibit at the Technology and Heart..
12/02/202422:00GLOBEDaxor Corporation Starts 2024 with Ongoing Growth in New..
07/02/202422:00GLOBEDaxor Corporation Closes Q4 2023 with Growth in New Sales to..
29/01/202422:00GLOBEDaxor Corporation to Exhibit at the Society of Nuclear..
16/01/202422:00GLOBEDaxor Corporation to Exhibit at the Society for Critical..
09/01/202422:00GLOBEDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME..
02/01/202422:52EDGAR2Form 8-K - Current report
02/01/202422:30GLOBEDaxor Corporation Submits Dual 510(k)/CLIA-waiver..
07/12/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202311:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202310:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202320:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202303:53EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
25/11/202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:00GLOBENew Randomized Controlled Trial Demonstrates the Efficacy of..
13/11/202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:00GLOBEDaxor Corporation Awarded New Patent for Remote Monitoring..
03/11/202307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202306:27EDGAR2Form 8-K - Current report
17/10/202301:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202321:00GLOBEExpert Panelists Advocate Use of Daxor’s Technology to..
11/10/202321:00GLOBENew Data from Banner University Medicine Demonstrating..
04/10/202321:00GLOBEDaxor Corporation Awarded Support from the National..
27/09/202321:00GLOBEDaxor Corporation to Exhibit at the Heart Failure Society of..
26/09/202322:14EDGAR2Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
26/09/202321:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
21/09/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202301:00GLOBEDaxor Corporation Awarded $305K Grant from the National..
07/09/202322:15GLOBEDaxor Corporation to Present at the H.C. Wainwright 25th..
29/08/202305:15GLOBEDaxor Corporation CEO and President Michael Feldschuh..
29/08/202305:05GLOBEDaxor Corporation Reports a 20.64 Percent Increase in..
29/08/202305:01EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
15/08/202320:14EDGAR2Form N-PX - Annual Report of proxy voting record of..
10/08/202321:00GLOBEJACC-HF Reports Successful Heart Failure Trial With Daxor..
14/07/202305:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/07/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/07/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
DXR
Daxor
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유